Why Nutex Health Inc.’s (NUTX) Stock Is Down 5.15%
As of Wednesday, July 22, Nutex Health Inc.’s NUTX share price has dipped by 5.15%, which has investors questioning if this is right time to buy.Michael Rose
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Nutex Health Inc. operates as a healthcare services and operations company in the United States. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The Hospital segment develops and operates a network of micro hospitals, specialty hospitals, and hospital outpatient departments that offer healthcare services, including emergency room care, inpatient care, and behavioural health. It also provides imaging services, such as CT scan, X-ray, MRI, ultrasound, etc.; laboratory services; and onsite inpatient pharmacies. The PHM segment provides management, administrative, and other support services to its affiliated hospitals and physician groups by establishing and operating provider networks, such as independent physician associations (IPAs); and a cloud-based technology platform for IPAs. The Real Estate segment owns and leases land and hospital buildings. Nutex Health Inc. was founded in 2011 and is headquartered in Houston, Texas.
Commentary & Analysis
Why Nutex Health Inc.’s (NUTX) Stock Is Up 5.23%
As of Tuesday, July 21, Nutex Health Inc.’s NUTX share price has surged by 5.23%, which has investors questioning if this is right time to sell.Jenna Brashear
Why Nutex Health Inc.’s (NUTX) Stock Is Down 6.74%
As of Wednesday, July 08, Nutex Health Inc.’s NUTX share price has dipped by 6.74%, which has investors questioning if this is right time to buy.Rosalio Madrigal
Why Nutex Health Inc.’s (NUTX) Stock Is Up 5.61%
As of Wednesday, July 01, Nutex Health Inc.’s NUTX share price has surged by 5.61%, which has investors questioning if this is right time to sell.Jenna Brashear
Why Nutex Health Inc.’s (NUTX) Stock Is Up 5.97%
As of Friday, June 26, Nutex Health Inc.’s NUTX share price has surged by 5.97%, which has investors questioning if this is right time to sell.Jenna Brashear
Financial Summary
| Share Statistics | NUTX | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $1,023.6 | $1,875.0 | 45% |
|
| Shares Out (Mil) | 7.2 | 77.1 | 17% |
|
| Institutional Ownership | 51.7% | 88.9% | 36% |
|
| Float (Mil) | 4.2 | 50.3 | 10% |
|
| Beta | 2.06 | 0.86 | 93% |
|
| Avg Daily Volume (000s) | 114 | 466 | 37% |
|
| Price Change (52-week) |
74.2% | 78.5% | 88% |
|
| Growth | NUTX | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 26.1% | 10.9% | 87% |
|
| Net Income (5yr) | (7.8%) | (1.1%) | 31% |
|
| EPS (5yr) | (17.1%) | 3.0% | 16 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | 38.7% | (18.2%) | 90% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | $4.954 | $21.520 | $23.030 | |
| Month Ago EPS | na | na | na | |
| # Rev Up | 0 | 1 | 0 | |
| # Rev Down | 0 | 0 | 1 | |
| Three Months Ago EPS | $4.490 | $19.590 | $20.330 | |
| Year/Year Chg | (24.0%) | 105.3% | na | |
| Financials | NUTX | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $880 | $1,464 | 49% |
|
| Net Income (TTM) (Mil) | $96 | $15 | 61% |
|
| EPS (TTM) | $14.402 | $0.300 | 97% |
|
| Operating Cash Flow (TTM) (Mil) | $273 | $138 | 63% |
|
| Net Cash Flow (TTM) (Mil) | $126 | $7 | 80% |
|
| Long-Term Debt (Q1) (Mil) | $323 | $323 | 55% |
|
| Enterprise Value (Q1) (Mil) | $1,273 | $2,130 | 44% |
|
| Valuation | NUTX | Industry Median |
Percentile (All Stocks) |
|
| P/B | 2.99 | 2.90 | 65% |
|
| P/E | 10.7 | 26.8 | 18% |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.1 | na |
|
| Ratios | NUTX | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 50.6% | 27.6% | 63% |
|
| Net Margin | 11.0% | 1.1% | 65% |
|
| ROA | 11.2% | 1.8% | 89% |
|
| ROE | 35.5% | 6.9% | 90% |
|
| Liabilities to Assets | 53.8% | 60.0% | 46% |
|
| F-Score | 5 | 5 | 51% |
|
Passing Stock Screens
As of 7/30/2026, from a list of 60 stock screening strategies,
GURU STRATEGY
Magic Formula Screen
Factors: Value, Quality
Joel Greenblatt's investing approach is based on finding companies with high return on investment that are trading for less than they are worth.
| Performance Since Inception: | 6.9% |
| +/- S&P 500: | -0.6 |
